377 related articles for article (PubMed ID: 30580088)
1. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
[TBL] [Abstract][Full Text] [Related]
2. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery.
Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J
J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019
[TBL] [Abstract][Full Text] [Related]
3. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide.
Xiong H; Guo Z; Zhang W; Zhong H; Liu S; Ji Y
J Photochem Photobiol B; 2014 Sep; 138():191-201. PubMed ID: 24976623
[TBL] [Abstract][Full Text] [Related]
4. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance.
Feng L; Li K; Shi X; Gao M; Liu J; Liu Z
Adv Healthc Mater; 2014 Aug; 3(8):1261-71. PubMed ID: 24652715
[TBL] [Abstract][Full Text] [Related]
5. DNA decorated Cu
Liang S; Xie Z; Wei Y; Cheng Z; Han Y; Lin J
Dalton Trans; 2018 Jun; 47(24):7916-7924. PubMed ID: 29790525
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.
Zhang X; Yang C; Zhou J; Huo M
Small; 2016 Jul; 12(26):3578-90. PubMed ID: 27244649
[TBL] [Abstract][Full Text] [Related]
7. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
9. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
10. Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery.
Wen H; Dong C; Dong H; Shen A; Xia W; Cai X; Song Y; Li X; Li Y; Shi D
Small; 2012 Mar; 8(5):760-9. PubMed ID: 22228696
[TBL] [Abstract][Full Text] [Related]
11. pH/NIR-responsive semiconducting polymer nanoparticles for highly effective photoacoustic image guided chemo-photothermal synergistic therapy.
Xu Y; Chen J; Tong L; Su P; Liu Y; Gu B; Bao B; Wang L
J Control Release; 2019 Jan; 293():94-103. PubMed ID: 30448086
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
[TBL] [Abstract][Full Text] [Related]
13. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
16. PEGylated hyaluronidase/NIR induced drug controlled release system for synergetic chemo-photothermal therapy of hepatocellular carcinoma.
Li H; Li H; Yu W; Huang S; Liu Y; Zhang N; Yuan J; Xu X; Duan S; Hu Y
Eur J Pharm Sci; 2019 May; 133():127-136. PubMed ID: 30779981
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Optimization of PEGylated Nano Graphene Oxide-Based Delivery System for Drugs with Different Molecular Structures Using Design of Experiment (DoE).
Shariare MH; Masum AA; Alshehri S; Alanazi FK; Uddin J; Kazi M
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800115
[TBL] [Abstract][Full Text] [Related]
18. PEGylated MoS
Liu L; Jiang H; Dong J; Zhang W; Dang G; Yang M; Li Y; Chen H; Ji H; Dong L
Colloids Surf B Biointerfaces; 2020 Jan; 185():110590. PubMed ID: 31670002
[TBL] [Abstract][Full Text] [Related]
19. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
20. PEGylated graphene oxide-capped gold nanorods/silica nanoparticles as multifunctional drug delivery platform with enhanced near-infrared responsiveness.
Qi Z; Shi J; Zhang Z; Cao Y; Li J; Cao S
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109889. PubMed ID: 31499943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]